Pharmaron 5 Newsletter

Pharmaron 5 is Pharmaron's quarterly newsletter that highlights fives stories we are eager to share. Each issue includes a story on a member of our team, along with updates on facilities, capabilities and latest events.

Read recent issues:

Q2 2018 Q2 2018
5 stories in this issue:
  • Meet Dr. Paolo DePetrillo, Medical Director at Pharmaron's Clinical Pharmacology Center in Baltimore, MD
  • A Thorough QT success story with Zavante Therapeutics
  • New strategic partnership with CR Medicon
  • Pharmaron's focus on science and innovation
  • Human Metabolism Studies at Pharmaron
Q1 2018 Q1 2018
5 stories in this issue:
  • Meet Dr. Fang He, Director in vitro Biology, leader of Pharmaron’s in vitro Screening Center
  • Client Success Story from Celgene-Receptos: Integrated Clinical Development Services – metabolite profiling/identification
  • Learning opportunities provided to our team to support Pharmaron’s ongoing commitment to excellence in science
  • Pharmaron’s partnership with Shanghai Institute of Organic Chemistry (SIOC), Chinese Academy of Sciences
  • Pharmaron’s in vitro biology department – focused on new model development
Q4 2017 Q4 2017
5 stories in this issue:
  • Meet Dr. Jingqi Huang, VP, in vivo Pharmacology
  • Pharmaron's 2017 Publications
  • Ningbo Site Opening Ceremony
  • Forum on Innovation for Life Sciences
  • Capability Focus: in vitro biology & in vivo Pharmacology
Q3 2017 Q3 2017
5 stories in this issue:
  • Meet Dr. Michael Rowley, Senior VP, Drug Discovery Services Europe
  • Partner Success Story: Lycera
  • Learning from Leaders
  • Successful CFDA Inspection
  • Capability: Integrated Services
Q2 2017 Q2 2017
5 stories in this issue:
  • Meet Dr. Adrian Waring, Dir. Metabolism, Radiolabelled Sci.
  • Acheiving FDA Approval
  • Pharmaron's Building Blocks
  • Pharmaron Acquires SNBL-CPC
  • Capability: Oligonucleotides, Radiolabelling and Metabolism
Q1 2017 Q1 2017
5 stories in this issue:
  • Meet Dr. Jufeng Wang, Senior VP, Safety Assessment        
  • Acheiving IND Filing Success
  • Site Opening in Hoddesdon, UK
  • Pharmaron Acquires Xceleron
  • Capability: SEND (Standard for Exchange of Nonclinical Data)
Q4 2016 Q4 2016
5 stories in this issue:
  • Meet Dr. Guosheng Wu, VP, Computational Drug Discovery
  • Reaching Critical Milestones
  • T.G.I.F. - Friday Seminars at Pharmaron
  • Supporting Future Scientists
  • Capability Focus: Compound Management System
Q3 2016 Q3 2016
5 stories in this issue:
  • Meet Dr. Hua Yang, Chief Scientific Officer
  • Partner Success: Nimbus Apollo
  • Innovation Inspiration
  • Future Leaders of Pharmaron
  • Capability Focus: CATLab

Learn About Our Services